Moxetumomab Pasudotox-tdfk and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Moxetumomab Pasudotox-tdfk and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Pneumococcal Conjugate Vaccine (7-Valent)
- Moxetumomab Pasudotox-tdfk-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Moxetumomab Pasudotox-tdfk-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Moxetumomab Pasudotox-tdfk-Pneumovax 23
- Moxetumomab Pasudotox-tdfk-PNV - Omega
- Moxetumomab Pasudotox-tdfk-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Moxetumomab pasudotox-tdfk Intravenous
- Pneumococcal Conjugate Vaccine (13-Valent)-Moxifloxacin
- Pneumococcal Conjugate Vaccine (13-Valent)-Moxifloxacin (Systemic)
- Pneumococcal Conjugate Vaccine (13-Valent)-Moxifloxacin Hydrochloride
- Pneumococcal Conjugate Vaccine (13-Valent)-Moxifloxacin Injection
- Pneumococcal Conjugate Vaccine (13-Valent)-Moxifloxacin Intravenous